Navitor Pharmaceuticals, Inc.
Clinical trials sponsored by Navitor Pharmaceuticals, Inc., explained in plain language.
-
New depression pill shows promise in early trial
Symptom relief CompletedThis study tested an experimental drug called SPN-820 in 40 adults with major depressive disorder. The goal was to see if the drug safely reduces depression symptoms over time. Researchers measured mood changes using standard depression rating scales.
Phase: PHASE2 • Sponsor: Navitor Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 17, 2026 09:49 UTC
-
New hope for hard-to-treat depression? drug NV-5138 tested in 250 adults
Symptom relief CompletedThis study tested whether NV-5138 can safely reduce depression symptoms in adults whose depression did not get better with standard treatments. About 250 participants took either the drug or a placebo for 4 weeks. The main goal was to see if their depression scores improved more …
Phase: PHASE2 • Sponsor: Navitor Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC